Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea · Delayed Price · Currency is KRW 8,310.00
-10.00 (-0.12%)
Last updated: Jun 4, 2026, 2:19 PM KST
KRX:007570 Revenue
Ilyang Pharmaceutical Co.,Ltd had revenue of 65.07B KRW in the quarter ending March 31, 2026, with 4.99% growth. This brings the company's revenue in the last twelve months to 275.51B, up 1.32% year-over-year. In the year 2025, Ilyang Pharmaceutical Co.,Ltd had annual revenue of 272.42B with 1.39% growth.
Revenue (ttm)
275.51B
Revenue Growth
+1.32%
P/S Ratio
0.54
Revenue / Employee
413.68M
Employees
666
Market Cap
149.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 272.42B | 3.74B | 1.39% |
| Dec 31, 2024 | 268.68B | 2.01B | 0.75% |
| Dec 31, 2023 | 266.67B | 18.90B | 7.63% |
| Dec 31, 2022 | 247.77B | 5.26B | 2.17% |
| Dec 31, 2021 | 242.51B | -100.82B | -29.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharmaceutical Co.,Ltd | 534.52B |
| Dongwha Pharm.Co.,Ltd | 501.33B |
| Kyongbo Pharmaceutical | 269.64B |
| HLB Pharmaceutical | 236.59B |
| Daihan Pharmaceutical | 211.44B |
| Samil Pharmaceutical Co.,Ltd | 210.51B |
| Hana Pharm | 139.33B |
| CMG Pharmaceutical | 110.12B |